HSCS — Heart Test Laboratories Cashflow Statement
0.000.00%
Last trade - 00:00- $2.39m
- -$4.19m
- $0.01m
- 26
- 30
- 24
- 16
Annual cashflow statement for Heart Test Laboratories, fiscal year end - April 30th, USD millions except per share, conversion factor applied.
2020 April 30th | 2021 April 30th | 2022 April 30th | 2023 April 30th | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -3.81 | -2.45 | -4.83 | -6.35 |
| Depreciation | ||||
| Amortisation | ||||
| Non-Cash Items | 0.103 | -0.224 | 0.033 | 0.38 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -0.196 | 0.19 | 1.12 | 0.174 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Prepaid Expenses | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Change in Other Liabilities | ||||
| Cash from Operating Activities | -3.84 | -2.45 | -3.64 | -5.77 |
| Capital Expenditures | -0.011 | -0.001 | -0.002 | -0.018 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | 0.02 | 0 | — | — |
| Sale of Fixed Assets | ||||
| Cash from Investing Activities | 0.008 | -0.001 | -0.002 | -0.018 |
| Financing Cash Flow Items | 0.3 | 0.7 | -0.385 | 0 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 1.81 | 2.68 | 3.84 | 6.53 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -2.02 | 0.227 | 0.195 | 0.742 |